-
Posted by
Two Blokes Jul 25 -
Filed in
Stock
-
3 views
The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents, the drugmaker said on Friday.
